Clinical Trial Update: Sildenafil and Pulmonary Artery Pressure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sildenafil for reducing pulmonary artery pressure in pulmonary hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Chicago | Conditions: Pulmonary Hypertension | Phase 2 | Status: TERMINATED